4.4 Article

Risk factors and characteristics associated with persistent smell loss in coronavirus disease 2019 (COVID-19) patients

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Airborne aerosol olfactory deposition contributes to anosmia in COVID-19

Alan D. Workman et al.

Summary: Experimental data confirms that small-sized (0.5-5 μm) airborne aerosols deposit in significant concentrations within the olfactory epithelium, providing a compelling aerodynamic mechanism to explain atypical olfactory dysfunction in COVID-19 patients.

PLOS ONE (2021)

Letter Rheumatology

Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis

Adem Kucuk et al.

CLINICAL RHEUMATOLOGY (2020)

Article Otorhinolaryngology

Olfactory and Gustatory Outcomes in COVID-19: A Prospective Evaluation in Nonhospitalized Subjects

Alberto Paderno et al.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2020)

Article Otorhinolaryngology

Prevalence and reversibility of smell dysfunction measured psychophysically in a cohort of COVID-19 patients

Shima T. Moein et al.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2020)

Article Otorhinolaryngology

Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms

Carol H. Yan et al.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2020)

Article Otorhinolaryngology

Sensitivity analysis and diagnostic accuracy of the Brief Smell Identification Test in patients with chronic rhinosinusitis

Edward El Rassi et al.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2016)